NanJing Pharmaceutical Co Ltd
SSE:600713
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
NanJing Pharmaceutical Co Ltd
NanJing Pharmaceutical Co Ltd
Other Current Assets
NanJing Pharmaceutical Co Ltd
Other Current Assets Peer Comparison
1099
601607
600998
000963
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Other Current Assets
¥1.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Current Assets
¥29.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Current Assets
¥5.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
18%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Current Assets
¥12.3B
|
CAGR 3-Years
58%
|
CAGR 5-Years
34%
|
CAGR 10-Years
20%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Current Assets
¥195.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
6%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Current Assets
¥750.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Other Current Assets?
Other Current Assets
1.2B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Other Current Assets amounts to 1.2B CNY.
What is NanJing Pharmaceutical Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
9%
Over the last year, the Other Current Assets growth was 0%. The average annual Other Current Assets growth rates for NanJing Pharmaceutical Co Ltd have been 13% over the past three years , 15% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
